02-09-2026 08:00
via wallstreet-online.de
Stimulating growth with surgical accuracy; INITIATE with BUY
We initate Nexstim coverage with a BUY rating at € 12 PT. This is a profitable, MedTech growth story, with the right foundations to scale the business.
Weiterlesen »
Analysten nachrichten
